|
Mass Spectrometry Group
|
Overview
Over the past 20 years the Institute has invested in a range of
mass spectrometry facilities. The majority are used to support a
wide array of metabolic studies in cells, animals and humans. Often
the dynamics (or fluxes) of nutrients and metabolites need to be
quantified. This requires tracer kinetic methodologies, whereby
the flow of a metabolite through various intermediary pathways and
into specific products is measured using either radio- or stable-isotopes.
In the past, such studies invariably used radio-isotopes due, in
part, to the ubiquitous availability of relatively cheap liquid
scintillation counters. Nowadays, and especially when studies on
humans are involved, safe stable-isotope forms of metabolites are
preferred. Measurement of these requires access to mass spectrometers,
with several different types necessary to allow the full array of
analyses to be accomplished. In more recent years the Institute
has also used mass spectrometry to support research in programmes
relating to metalloproteins, collagen crosslinks and peptide mass
mapping. Using a combination of these instruments, we are able to
identify proteins by peptide mass fingerprinting and de novo sequencing
following 2D PAGE electrophoresis. Our most recent purchases have
been the Applied Biosystems 4000 Q Trap and 3200 LC/MS/MS instruments.
This will support the increasing interest in quantitative metabolite
measurements and Metobolomics.
|